Xing L, He Q, Xie L, Wang H, Li Z. Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review. Haematologica 2022;107(5):1226-1228; https://doi.org/10.3324/haematol.2021.280259.